RetinaCME
EXPERT VIDEOCME

Rapid Response from Chicago: Advances in the Long-term Management of Non-infectious Uveitis

Author(s)/Faculty: Thomas A. Albini, MD; Quan Dong Nguyen, MD, MSc; Sumit Sharma, MD
Release Date: 11/8/2018Expiration Date: 11/7/2019
Credit Type: CMENumber of Credits: 0.75
Content Type: VideoProvider:
Non-infectious uveitis is a leading cause of preventable blindness worldwide. To avert potential severe vision loss, timely diagnosis and the initiation of an effective management protocol is imperative. Systemic corticosteroids have been the gold standard and an effective first-line therapy for non-infectious uveitis, but the side effects associated with their long-term administration warrant the utilization of other therapy options. New nonsteroidal therapies have recently been approved, and other agents are currently under investigation for the treatment of non-infectious uveitis. For effective incorporation of these agents in management protocols, it is essential that their optimal use and safety profiles are understood and considered. In this Rapid Response from Chicago 2018, experts in the field provide discussion on the need for nonsteroidal options for the long-term management of non-infectious uveitis and evaluate the latest clinical evidence regarding new and emerging nonsteroidal options for long-term treatment of the disease.